login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Scientists Discover New Vaccine Approach To Treat Cancer
And the team at Trinity College Dublin, Ireland, led by Professor Kingston Mills, Professor of Experimental Immunology, have also developed a new vaccine to treat cancer at the pre-clinical level.
The discovery has been patented and there are plans to develop the vaccine for clinical use for cancer patients.
The first cancer vaccine Sipuleucel-T (Provenge(tm)) was licensed last year for use in prostate cancer patients unresponsive to hormone treatment.
Unfortunately, this cell-based vaccine only improves patient survival by an average of 4.1 months.
Vaccines for infectious diseases are highly effective at generating immune responses that prevent infection with bacteria or viruses. The immune system can also protect us against tumors and in theory a vaccine approach should be effective against cancer.
In practice this has proven very difficult because unlike infectious diseases, tumors are derived from normal human cells, and not made up of foreign substances or antigens capable of triggering an immune response.
The tumors instead produce molecules that suppress the efficacy of the immune system. They generate regulatory cells that inhibit the immune response that could potentially clear the tumors.
Professor Mills' group has developed a novel vaccine and immunotherapeutic approach that can overcome these obstacles and has the potential to significantly improve on existing technologies.
The therapy is based on a combination of molecules that manipulates the immune response to curb the regulatory arm while enhancing the protective arm, allowing the induction of specialist white blood cell called killer T cells to target and eliminate the tumors. The new vaccine approach was found to be highly effective at pre-clinical stage in treating a range of cancers in murine models.
The findings were published in December online in Cancer Research, the leading journal of The American Association of Cancer Research.
Source-ANI
|
|
More News on: Cancer and Homeopathy, Cancer Facts, Cancer, Tattoos A Body Art, Vaccination for Children
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
 | Quiz on Cancer Looking for information on cancer? Go through medindia's Cancer quiz. 
|
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Cancer
Complete Medindia Resources
|
| News Categories: |
| » | Research Reveals Skp2 Activates Cancer-Promoting, Glucose-Processing Akt |
| » | Researchers Reveal New Findings About Cancer Cell Metabolism |
| » | Psychological Science Gets Behind the Scenes on the Raging Issue About Prostate-cancer Screenings |
| » | Botanical Formula Slows Breast Cancer Metastasis |
| » | Scientists See Potential in New Leukemia Treatment |
| More Cancer News | |
|
Clinical Trials Related News |
||||||||
| » | Heat Shock Protein Inhibitor And Hormonal Therapy Combo Tested in Breast Cancer Clinical Trial | » | Novel Pancreatic Cancer Vaccine Shows Promise in Improving Survival | |||||
| » | Clinical Trials into New Drug Targeting Abnormal Genes Responsible for Cancer Provide Encouraging Results in Phase I Trial | » | Drug for Melanoma Shows Promise in Early Trial | |||||
| » | Experimental Drug may Help Older Chronic Leukemia Patients | » | Experimental Drug Delays Relapses in Multiple Myeloma | |||||
| » | Researchers Closer to Meningitis B Vaccine | » | Curb Slaughtering Animals Without Prior Stunning | |||||
| Read More >> | ||||||||
